While the value of face-to-face, personal HCP interactions remain impactful, the efficacy, adoption, and ROI of digital, non-personal engagement continues to increase. IQVIA experts will discuss the imperatives for an agile and flexible engagement model for emerging biopharma; one that's fit for today's realities while being ready for what tomorrow will bring.
The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. Learn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them.
Learn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. Our experts will share segment trends and break down the components of successful commercialization.
Christie Conn
Vice President, Brand & Commercial Strategy, IQVIA
Matthew Smith
Senior Principal, Consulting Services, IQVIA
Flexible solutions. Responsive teams. Data-driven insights.
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.
